Clinical trial
A Study of AZD0120 in Autoimmune Diseases
NCT07295847
Study timeline
Study start (actual)2026-01-09Date precision: day
Registry last updated2026-07-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Systemic Sclerosisunresolved
Idiopathic Inflammatory Myopathiesunresolved
Rheumatoid Arthritisunresolved
Interventions
AZD0120BIOLOGICAL
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
MadridSpain2New YorkNew York, United States1ChicagoIllinois, United States1St LouisMissouri, United States1BarcelonaSpain1LondonUnited Kingdom1SeattleWashington, United States1BerlinGermany1Ann ArborMichigan, United States1TucsonArizona, United States1Chapel HillNorth Carolina, United States1HamburgGermany1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07295847 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.